《美国股市》道指跌1点 标普500指数破顶 思科跌逾7%
美股个别发展,标普500指数创收市新高,道指及纳指微跌。思科系统季绩展望欠佳带动科技股下跌。《金融时报》报道指中方让步不足使美国减少对中国货关税,市场态度观望。道指中段曾跌106点,尾市跌幅收窄。
道琼斯工业平均指数跌1.63点或0.01%,收报27,781.96点。
标准普尔500指数升2.59点或0.1%,收报3,096.63点。
纳斯达克指数跌3.08点或0.04%,收报8,479.02点。
思科系统股价跌7.3%,为跌幅最大道指成分股。迪士尼早前急升後回吐1.1%。波音公司升1.4%,为升幅最大道指成分股。维权投资者伊坎投资惠普股份,试图促成与施乐合并,施乐及惠普股价各升近3%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.